Peripherally acting NMDAR antagonists as new anti-diabetic medication. Novel approach for the reduction of blood sugar levels without risk of hypoglycaemia.
[Detail]
The invention describes a preparation as electrolyte for LiTFSi-containing lithium batteries. It contains cyclopentane carbonitrile and methoxyprionitrile as its main constituent and prevents corrosion on aluminum current conductors.
[Detail]
The invention describes a preparation as electrolyte for LiTFSi-containing lithium batteries.
[Detail]